Drug Topics

FEBRUARY 4, 2025

In a systematic review, researchers explored how biofeedback impacted rehabilitation in patients experiencing chronic pain disorders.

464

464

The Checkup by Singlecare

FEBRUARY 4, 2025

If you have a stubborn bacterial infection, your healthcare provider may prescribe a potent antibiotic like the brand-name medication Bactrim. Bactrim (sulfamethoxazole-trimethoprim), which contains the same activ e ingredients as Septra, is a sulfonamide antibiotic commonly used to treat urinary tract infections, traveler’s diarrhea, middle ear infections, bronchitis, and severe forms of pneumonia known as pneumocystis jirovecii and pneumocystis carinii pneumonia.

Adverse Reactions 83

Adverse Reactions Immunization 83

Drug Topics

FEBRUARY 4, 2025

Children with type 1 diabetes who watched educational videos and played games had improved glycemic control and quality of life.

332

332

Pharmacy Times

FEBRUARY 4, 2025

Investigators noted that the differences between the 3 respiratory infections were not as pronounced during the 2023-2024 season.

157

157

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 4, 2025

The drug will be made available in the second quarter of 2025.

FDA 281

FDA 281

The Checkup by Singlecare

FEBRUARY 4, 2025

Farxiga and Jardiance are two brand-name oral medications approved by the U.S. Food and Drug Administration (FDA) to manage Type 2 diabetes mellitus. Both are sodium-glucose cotransporter 2 (SGLT2) inhibitors. Farxiga, manufactured by AstraZeneca, contains the active drug dapagliflozin, and Jardiance, manufactured by Boehringer Ingelheim Pharmaceuticals, contains the active drug empagliflozin.

Hospitals 52

Hospitals Insurance Adverse Reactions Insurance Coverage 52

Pharmacy Times

FEBRUARY 4, 2025

Investigators found that 60% of individuals with type 2 diabetes are vitamin D deficient.

136

136

Drug Topics

FEBRUARY 4, 2025

Sodium-glucose cotransporter 2 inhibitors are more cardioprotective in older adults and glucagon-like peptide-1 receptor agonists for younger patients.

247

247

Pharmacy Times

FEBRUARY 4, 2025

World Cancer Day, observed annually on February 4th, is a global initiative aimed at raising awareness, reducing stigma, and promoting equitable access to cancer care, with pharmacy professionals playing a vital role in prevention, treatment, and support for patients and communities.

136

136

Drug Topics

FEBRUARY 4, 2025

Discover effective solutions to tackle the growing issue of drug shortages with our comprehensive white paper.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

DiversifyRx

FEBRUARY 4, 2025

Your pharmacy team will either be your greatest strength or your weakest link. Pharmacy Team development is a critical pillar for independent pharmacy owners aiming to enhance operational efficiency, boost employee satisfaction, and improve patient care. Investing in your team’s growth fosters a positive work environment and directly contributes to your pharmacy’s success.

Independent Pharmacies 52

Independent Pharmacies Patient Care Communication 52

Drug Topics

FEBRUARY 4, 2025

Discover effective solutions to tackle the growing issue of drug shortages with our comprehensive white paper.

247

247

Pharmacy Times

FEBRUARY 4, 2025

The approval marks the first subcutaneous infusion device approved for the treatment of Parkinson disease, providing a new option for patients with serious disease who are unresponsive to other therapies.

FDA 131

FDA 131

Drug Topics

FEBRUARY 4, 2025

Researchers addressed the factors leading to and the rates of discontinuation and reinitiation of GLP-1 RAs among adults with obesity.

247

247

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

FEBRUARY 4, 2025

The removal of thousands of health information web pages and public health data streams harms patients and runs counter to health agencies' mandate, Doctors for America argues in a newly filed lawsuit.

130

130

Drug Topics

FEBRUARY 4, 2025

Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed tactics and challenges health-system pharmacy encounters within the distribution of patient benefits.

247

247

Fierce Healthcare

FEBRUARY 4, 2025

A federal appeals court axed a $650 million judgment and corresponding injunction against CVS Pharmacy, Walgreens Boots Alliance and Walmart stemming from a lawsuit filed by two Ohio counties in 2018.

116

116

Drug Topics

FEBRUARY 4, 2025

The therapy is now the first and only FDA-approved treatment that maintains vision with fewer treatments compared to standard-of-care injections.

FDA 190

FDA 190

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

FEBRUARY 4, 2025

Patient experience monitoring company Press Ganey announced a strategic partnership with Microsoft to further integrate AI into its existing solutions.

116

116

Pharmaceutical Technology

FEBRUARY 4, 2025

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

100

100

pharmaphorum

FEBRUARY 4, 2025

After setbacks with psychedelics, phase 2b data with GH Research's GH001 for treatment-resistant depression could lift confidence in the category

94

94

The Guardian - Pharmaceutical Industry

FEBRUARY 4, 2025

Group action with 3,500 claimants alleges company knew its talcum powder products contained dangerous asbestos Lawyers representing 3,500 claimants are preparing to sue the pharmaceutical firm Johnson & Johnson (J&J) over alleged links between talcum powder and cancer, in what is expected to be one of the largest pharmaceutical product group actions in English and Welsh legal history.

89

89

pharmaphorum

FEBRUARY 4, 2025

Revolutionise your research process with Axtria Rapid CSR to produce faster and more accurate clinical study reports. Improve efficiency and accuracy in your clinical studies with these advanced solutions.

92

92

Pharmacy Times

FEBRUARY 4, 2025

Prescription stimulant dispensing was greatly impacted by the COVID-19 pandemic and drug shortages.

81

81

pharmaphorum

FEBRUARY 4, 2025

A GABA-targeting drug developed by German Biotech Algiax has shown proof of concept in a chronic neuropathic trial trial.

87

87

Pharmacy Times

FEBRUARY 4, 2025

Some risk factors for chronic kidney disease (CKD) in patients with lupus nephritis (LN) and systemic lupus erythematosus (SLE) were renal impairment, delayed diagnosis, and hypertension.

81

81

pharmaphorum

FEBRUARY 4, 2025

Pfizer's Braftovi, just approved by the FDA as a first-line treatment for colorectal cancer based on response data, also extends patient survival.

FDA 86

FDA 86

STAT

FEBRUARY 4, 2025

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!

79

79

Fierce Healthcare

FEBRUARY 4, 2025

Centene Corporation reported $283 million in profit for the fourth quarter of 2024, a notable bump from the fourth quarter of 2023's haul of $45 million.

75

75

Pharmacy Times

FEBRUARY 4, 2025

Overall, there is no long-term increased risk of developing thyroid cancer after initiating treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, although there is a short-term increase.

73

73

pharmaphorum

FEBRUARY 4, 2025

Nearly 700,000 women will be recruited into an NHS trial of AI tools for breast cancer screening, in the hope of relieving pressure on radiologists.

69

69

Pharmacy Times

FEBRUARY 4, 2025

Tocilizumab-anoh is expected to increase competition, improve patient access, and deliver cost savings in the treatment of various inflammatory conditions.

FDA 73

FDA 73

Pharmaceutical Technology

FEBRUARY 4, 2025

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

69

69